The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI Cohort.

doi:10.1007/s40263-025-01237-w

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI Cohort.

CNS drugs - 1 Feb 2026

Silva Patrick, Costa Marina A, Gaspar Laetitia, Durães João, Cunha Inês, Ribeiro Joana A, Januário Cristina, Oliveiros Bárbara, Hübener-Schmid Jeannette, Faber Jennifer, Raposo Mafalda, Lima Manuela, Garcia-Moreno Hector, Giunti Paola, Beichert Lukas, Schöls Ludger, van de Warrenburg Bart P, de Vries Jeroen, Thieme Andreas, Reetz Kathrin, Jacobi Heike, Infante Jon, Klockgether Thomas, de Almeida Luís Pereira, Santana Magda M

Abstract excerpt

BACKGROUND AND OBJECTIVES: Spinocerebellar ataxia type 3 (SCA3) is one of the most common dominantly inherited ataxias worldwide. Despite research advances, no approved disease-modifying treatment exists, and management focuses on symptom alleviation and functional capacity maximization. Symptomatic treatment guidelines are scarce, leaving decisions to physicians' discretion. The lack of studies on SCA3 symptom...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ataxin-3

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Cross-Sectional Studies

Share to Disease Progression

Share to Europe

Share to Heterozygote

Share to Longitudinal Studies

Share to Machado-Joseph Disease

Source

Open in PubMed Open full text

Identifiers

PMID: 41105366
DOI: 10.1007/s40263-025-01237-w
PMCID: PMC12855365

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI Cohort.PMID 41105366Read ↗

The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI CohortSemantic proximity Read ↗

Episodic Ataxias: Primary and Secondary Etiologies, Treatment, and Classification Approaches.Semantic proximity Read ↗

Effect of levodopa/carbidopa on the progression of Machado-Joseph disease /spinocerebellar ataxia type 3 (MJD/SCA3)Semantic proximity Read ↗

Identifying Therapeutic Targets for Spinocerebellar Ataxia Type 3/Machado–Joseph Disease through Integration of Pathological Biomarkers and Therapeutic StrategiesSemantic proximity Read ↗

Pharmacological Therapies for Machado-Joseph Disease.Semantic proximity Read ↗

Dysphagia Linked to Clinical Phenotype and Disease Progression in Spinocerebellar Ataxia Type 3Semantic proximity Read ↗

Stage‐Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3Semantic proximity Read ↗

Caring for Machado-Joseph disease: current understanding and how to help patients.Semantic proximity Read ↗

Capturing clinical progression in multisystemic genetic ataxias: lessons from a prospective study of 884 patients with autosomal recessive or early-onset ataxiaSemantic proximity Read ↗

A chlorzoxazone-baclofen combination improves cerebellar impairment in spinocerebellar ataxia type 1Semantic proximity Read ↗

Neurochemical abnormalities in premanifest and early spinocerebellar ataxiasSemantic proximity Read ↗

Progression of biological markers in spinocerebellar ataxia type 3: analysis of longitudinal data from the ESMI cohortSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.